373 related articles for article (PubMed ID: 18221243)
1. Modulation of sirtuins: new targets for antiageing.
Pallàs M; Verdaguer E; Tajes M; Gutierrez-Cuesta J; Camins A
Recent Pat CNS Drug Discov; 2008 Jan; 3(1):61-9. PubMed ID: 18221243
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol--a boon for treating Alzheimer's disease?
Anekonda TS
Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin activators and inhibitors.
Villalba JM; Alcaín FJ
Biofactors; 2012; 38(5):349-59. PubMed ID: 22730114
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol for Alzheimer's disease.
Sawda C; Moussa C; Turner RS
Ann N Y Acad Sci; 2017 Sep; 1403(1):142-149. PubMed ID: 28815614
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons.
Alvira D; Yeste-Velasco M; Folch J; Verdaguer E; Canudas AM; Pallàs M; Camins A
Neuroscience; 2007 Jul; 147(3):746-56. PubMed ID: 17583434
[TBL] [Abstract][Full Text] [Related]
7. SIR2: a potential target for calorie restriction mimetics.
Chen D; Guarente L
Trends Mol Med; 2007 Feb; 13(2):64-71. PubMed ID: 17207661
[TBL] [Abstract][Full Text] [Related]
8. Trans-resveratrol: a magical elixir of eternal youth?
Orallo F
Curr Med Chem; 2008; 15(19):1887-98. PubMed ID: 18691046
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of human SIRT1 activation by resveratrol.
Borra MT; Smith BC; Denu JM
J Biol Chem; 2005 Apr; 280(17):17187-95. PubMed ID: 15749705
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin deacetylases in neurodegenerative diseases of aging.
Herskovits AZ; Guarente L
Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
[TBL] [Abstract][Full Text] [Related]
11. Sirtuins in aging and disease.
Guarente L
Cold Spring Harb Symp Quant Biol; 2007; 72():483-8. PubMed ID: 18419308
[TBL] [Abstract][Full Text] [Related]
12. Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseases.
Ramis MR; Esteban S; Miralles A; Tan DX; Reiter RJ
Mech Ageing Dev; 2015 Mar; 146-148():28-41. PubMed ID: 25824609
[TBL] [Abstract][Full Text] [Related]
13. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Huber K; Superti-Furga G
Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
[TBL] [Abstract][Full Text] [Related]
14. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer.
Morris BJ
J Hypertens; 2005 Jul; 23(7):1285-309. PubMed ID: 15942449
[TBL] [Abstract][Full Text] [Related]
15. Substrate-specific activation of sirtuins by resveratrol.
Kaeberlein M; McDonagh T; Heltweg B; Hixon J; Westman EA; Caldwell SD; Napper A; Curtis R; DiStefano PS; Fields S; Bedalov A; Kennedy BK
J Biol Chem; 2005 Apr; 280(17):17038-45. PubMed ID: 15684413
[TBL] [Abstract][Full Text] [Related]
16. A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.
Imai S
Pharmacol Res; 2010 Jul; 62(1):42-7. PubMed ID: 20085812
[TBL] [Abstract][Full Text] [Related]
17. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
[TBL] [Abstract][Full Text] [Related]
18. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
Howitz KT; Bitterman KJ; Cohen HY; Lamming DW; Lavu S; Wood JG; Zipkin RE; Chung P; Kisielewski A; Zhang LL; Scherer B; Sinclair DA
Nature; 2003 Sep; 425(6954):191-6. PubMed ID: 12939617
[TBL] [Abstract][Full Text] [Related]
19. Neuronal protection by sirtuins in Alzheimer's disease.
Anekonda TS; Reddy PH
J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin activators.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
